FindTrial
Sign In

Edotecarin

DRUG5 trials

Sponsors

Pfizer, Memorial Sloan Kettering Cancer Center

Conditions

Breast CancerBreast NeoplasmsEsophageal CancerGastric CancerGlioblastomaNeoplasm MetastasisStomach NeoplasmsUnspecified Adult Solid Tumor, Protocol Specific

Phase 1

Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
CompletedNCT00072332
Memorial Sloan Kettering Cancer CenterEsophageal Cancer, Gastric Cancer, Unspecified Adult Solid Tumor, Protocol Specific
Start: 2003-08-31End: 2009-12-31Updated: 2013-12-19

Phase 2

Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy
CompletedNCT00067314
PfizerBreast Neoplasms, Neoplasm Metastasis
Start: 2003-06-30End: 2007-06-30Target: 65Updated: 2012-01-18
Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Chemotherapy
CompletedNCT00070031
Memorial Sloan Kettering Cancer CenterBreast Cancer
Start: 2003-06-30End: 2009-12-31Updated: 2013-12-19
Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy
CompletedNCT00087503
PfizerStomach Neoplasms
Start: 2004-04-30End: 2005-06-30Target: 28Updated: 2008-04-01

Phase 3

Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme
CompletedNCT00068952
PfizerGlioblastoma
Start: 2003-08-31End: 2006-03-31Target: 118Updated: 2008-04-01